HighTide’s First-In-Class Diabetes Contender Numerically Superior To Farxiga Glycemic Control

 
• By Dexter Jie Yan
  
Nurse making a blood test. . Man's hand with red blood drop with Blood glucose test strip and Glucose meter.
HighTide Therapeutics’ HTD1801has scored numerical superiority in glycemic control over AstraZeneca’s Farxiga. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Clinical Trials